By Jeremy Watson , Megan MacGarvie, and John McKeon
Technological change has led to a rapid and dramatic evolution of business models in copyright-intensive industries, especially in the music industry.
By Melanie Arntz, Cäcilia Lipowski, Guido Neidhöfer and Ulrich Zierahn-Weilage
The effect of social background on professional success decreases when technological change is strong.
By Po-Hsuan Hsu, Hsiao-Hui Lee, and Tong Zhou
In order to accelerate knowledge accumulation and technical progress, governments introduced patent systems to encourage inventors to share their ideas, discoveries, and inventions with the public.
By Andreas Lichter, Max Löffler, Ingo E. Isphording, Thu-Van Nguyen, Felix Poege, Sebastian Siegloch
Advances in pharmaceuticals and vaccines, robotics and artificial intelligence dominate newspaper headlines.
By Tal Gross, Adam Sacarny, Maggie Shi & David Silver
America spends about 6 cents of every dollar at its hospitals. A natural question to ask: why not just pay those hospitals less?
By Stuart V. Craig, Keith Marzilli Ericson, and Amanda Starc
We examined how prices vary between insurers for the same procedure at the same hospital, using a dataset of all commercial Massachusetts hospital claims.
Iain Cockburn, Tim Wilsdon, Michele Pistollato, Rajini Jayasuriya, and Thomas Watson
The 1995 TRIPS Agreement between member states of the World Trade Organization (WTO) defines minimum standards of intellectual property (IP) protection and enforcement.
Insurers heavily subsidize the cost of ivermectin prescriptions for COVID, despite the lack of evidence that ivermectin is effective for COVID. In a new paper, published in JAMA, Questrom professor and TPRI co-lead Rena Conti with colleagues Kao-Ping Chua and Nora Becker (both University of Michigan) estimate that U.S. insurers may have wasted $2.5 million on these drugs in the week of August 13, 2021 alone.
TPRI faculty co-lead and Questrom faculty Rena Conti will testify at the upcoming U.S. House of Representatives hearing of the Committee on Oversight and Reform, entitled “Unsustainable Drug Prices: Findings from the Committee’s Drug Pricing Investigation and the Need for Structural Reforms.” on Friday, December 10, 2021, at 10 a.m. Professor Conti will discuss recently published papers germane to the current public debate on lowering prescription drug prices.
James Bessen, Erich Denk, Joowon Kim, Cesare Righi
This paper reports the first recent estimates of trends in the displacement of industry-leading firms. Displacement hazards rose for several decades since 1970 but have declined sharply since 2000. Using a production function-based model to explore the role of investments, acquisitions, and lobbying, we find that investments by dominant firms in intangibles, especially software, are distinctly associated with greater persistence and reduced leapfrogging.